Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.
To promote the responsible and effective use of antibiotics, reduce antibiotic resistance, and ensure patient safety through standardized prescribing practices.
Scope
These guidelines apply to all healthcare providers prescribing antibiotics within the Neftaly healthcare system.
1. General Principles
Antibiotics should only be prescribed when there is clear evidence or strong clinical suspicion of a bacterial infection.
Avoid antibiotics for viral infections or non-infectious conditions.
Use the narrowest spectrum antibiotic effective for the infection.
Prescribe the correct dose and duration based on current clinical evidence.
Consider patient allergies, comorbidities, renal and hepatic function before prescribing.
2. Diagnosis and Assessment
Confirm bacterial infection through clinical evaluation and, where appropriate, laboratory and microbiological tests.
Obtain cultures before starting antibiotics when possible.
Assess severity of illness to guide the need for oral vs. intravenous antibiotics.
3. Antibiotic Selection
Follow local antibiogram data to select empirical antibiotics.
First-line agents should be chosen based on infection type (see infection-specific guidance).
Reserve broad-spectrum antibiotics for resistant infections or severe cases.
Adjust therapy according to culture results and clinical response.
4. Dosage and Duration
Adhere to recommended dosing schedules.
Use the shortest effective duration to reduce resistance risk.
Typical durations:
Uncomplicated urinary tract infection: 3–5 days
Community-acquired pneumonia: 5–7 days
Skin and soft tissue infections: 5–10 days
Others as per specific infection guidelines
5. Monitoring and Follow-Up
Reassess patients 48–72 hours after starting antibiotics.
Modify therapy based on clinical response and lab results.
Monitor for adverse effects and signs of antibiotic toxicity.
Educate patients on completing the full course unless otherwise directed.
6. Special Populations
Adjust dosing in pediatric, elderly, pregnant, and renal/hepatic impaired patients.
Consult specialists for immunocompromised patients or complicated infections.
7. Avoiding Common Pitfalls
Do not prescribe antibiotics for viral infections like colds or flu.
PSA blood test is the first-line screening tool. Digital rectal exams (DREs) are not recommended routinely for asymptomatic men due to lack of added benefit Journals.co.za.
High-risk groups should begin screening earlier:
All men from age 50.
Black African men and those with a family history (prostate or breast cancer in a first-degree relative), from age 45.
Men with BRCA1/2, HOXB13, ATM, or CHEK2 gene mutations should start at 40, or 10 years younger than the youngest affected relative Journals.co.za.
Screening intervals should be individualized—some guidelines allow up to 8 years between tests, but more frequent testing may be justified in Black African men due to higher risk Journals.co.za.
Pause screening if recent events may raise PSA temporarily:
Acute prostatitis, urinary retention, urethral instrumentation, or recent prostate surgery—defer by 6–8 weeks Journals.co.za.
Repeat PSA if elevated but <10 ng/mL (“grey zone”) and DRE is normal. Abstain from ejaculation or cycling for ≥48 hours before repeat testing Journals.co.za.
Use free/total PSA ratio for added specificity when total PSA is in the grey zone:
Adjust PSA level for men on 5-alpha-reductase inhibitors (finasteride or dutasteride): multiply PSA by 2 Journals.co.za.
Do not prescribe antibiotics or alpha-blockers to lower PSA in asymptomatic men without infection Journals.co.za.
Refer to a urologist when PSA remains persistently elevated (age-adjusted) or DRE is abnormal. In resource‐limited settings, very high PSA (e.g., >50 ng/mL) may suggest metastatic disease and prompt treatment even without biopsy Journals.co.za.
Summary Table:
Group / Situation
Guideline
Asymptomatic, informed, life > 10 yrs
Offer PSA screening
Age > 70 or life < 10 yrs
Do not screen generally
High-risk (Black, family history)
Start from age 45
Genetic mutation carriers
Start from age 40 (or 10 yrs younger than young relative)
Elevated PSA (<10 ng/mL)
Repeat test after abstinence; consider free/total ratio
On 5-ARI therapy
Adjust PSA by doubling
Suspicious results / high PSA
Refer to urologist; possible immediate treatment
Additional Context: Prostate Screening Practices in South Africa
Beyond formal guidelines, local health authorities and organizations highlight early detection and awareness:
Western Cape Health Department encourages annual screening for men aged 50+, especially with family history, aligning with the National Integrated Men’s Health Strategy 2020–2025 Western Cape Government.
The Prostate Cancer Foundation of South Africa advises:
All men over 45 get screened annually.
High-risk men (Black or family history) start at age 40yeswecare.co.za.
Community efforts like workshops and PSA drives (e.g., outreach by The Urology Hospital in Pretoria) are happening during Men’s Health Month, emphasizing early screening, particularly for men 45+ with family historyurology.co.za.
Your Action Plan (Johannesburg Context)
If you or someone you know is considering prostate screening:
Have an informed discussion with a healthcare provider about the risks and benefits.
If asymptomatic, consider PSA testing in line with age and risk profile.
Proceed with the PSA test alone unless DRE is clinically indicated.
Interpret results appropriately:
If PSA is “grey zone” (e.g., 4–10 ng/mL), consider repetition and free/total PSA evaluation.
Adjust PSA if the person is on finasteride or dutasteride.
Encourage awareness:
Share with families and communities, especially Black men, about earlier and regular screening given higher local risk.
Support community health efforts like workshops or screenings during awareness months.
Engage your healthcare provider:
Use shared decision-making tools.
Personalized screening intervals based on prostate risk factors and baseline PSA levels.
Let me know if you’d like to explore:
Specific Johannesburg-based screening programs or clinics offering PSA testing.
Tools or pamphlets for patient education on prostate health.
How to facilitate informed decision-making in clinics or community settings.
Migraine is a common and disabling neurological disorder that affects people of all ages and backgrounds. It is characterized by recurring headaches, often accompanied by nausea, vomiting, and sensitivity to light or sound.
The Neftaly Migraine Management Guidelines aim to provide healthcare providers with a standardized, evidence-based approach for the diagnosis, treatment, and long-term management of migraines. These guidelines are tailored for both primary care and community health settings to ensure accessible and effective care for all patients.
2. Objectives
Improve accurate diagnosis of migraine in diverse clinical settings
Guide evidence-based acute and preventive treatment
Reduce migraine frequency, severity, and impact on quality of life
Promote patient education and self-management
Ensure safe referral of complex or refractory cases
3. Understanding Migraine
3.1 Types of Migraine
Type
Description
Migraine without Aura
Most common type; moderate to severe pulsating headache, often one-sided, with nausea and sensitivity to light/sound.
Migraine with Aura
Headache preceded by reversible visual, sensory, or speech disturbances.
Chronic Migraine
Headache occurring ≥15 days/month for ≥3 months, with features of migraine on ≥8 days/month.
Menstrual Migraine
Occurs around menstruation, often without aura.
3.2 Common Triggers
Stress or emotional disturbance
Hormonal changes
Skipped meals or dehydration
Certain foods (e.g., aged cheese, chocolate, caffeine)
Bright lights or loud noise
Sleep disturbances
Weather changes
4. Diagnostic Criteria (ICHD-3)
Migraine without Aura:
At least 5 attacks fulfilling the following:
Lasts 4–72 hours
At least 2 of the following: unilateral, pulsating, moderate to severe, aggravated by activity
At least 1 of the following: nausea/vomiting or photophobia/phonophobia
Use weight-appropriate doses of ibuprofen or paracetamol
Lifestyle modifications crucial
Avoid adult-specific preventives unless guided by a specialist
9. Referral Guidelines
Refer to a neurologist or headache specialist if:
Diagnosis is uncertain (e.g., red flags suggesting secondary causes)
Severe or disabling migraines despite treatment
Chronic migraine or medication-overuse headache
Neurological symptoms (e.g., weakness, confusion) during aura
Need for advanced therapy (e.g., CGRP inhibitors, Botox)
10. Red Flags: “SNOOP” for Secondary Headaches
Red Flag
Indicator
S – Systemic
Fever, weight loss, cancer, HIV
N – Neurological signs
Confusion, weakness, visual changes
O – Onset
Sudden or thunderclap headache
O – Older age
First onset after age 50
P – Pattern change
Progressively worsening or new type
Urgent evaluation (CT/MRI) needed if any red flags are present.
11. Patient Education and Support
Teach patients to:
Recognize early signs of migraine
Maintain a headache diary
Use medications correctly
Understand the importance of preventive measures
Provide written action plans and emergency contacts
12. Monitoring and Evaluation
Assess frequency, severity, and impact of migraine monthly
Use tools like:
MIDAS (Migraine Disability Assessment)
HIT-6 (Headache Impact Test)
Adjust treatment based on response and side effects
13. Conclusion
Migraine is manageable with the right combination of medication, lifestyle, and education. Neftaly’s Migraine Management Guidelines empower frontline healthcare workers to deliver effective, compassionate, and timely care — reducing the burden of migraines on individuals, families, and health systems.
For clinical tools, referral protocols, or training support, contact the Neftaly Neurology and Non-Communicable Disease Unit.
Iron deficiency is the most common nutritional deficiency worldwide, leading to anemia, impaired cognitive development, reduced work capacity, and adverse pregnancy outcomes. Iron supplementation is a critical intervention to prevent and treat iron deficiency anemia (IDA) across different population groups.
Neftaly’s Iron Supplementation Guidelines provide evidence-based recommendations to optimize iron intake, improve anemia control, and enhance overall health.
2. Objectives
Prevent iron deficiency and anemia in high-risk populations
Treat diagnosed iron deficiency anemia effectively
Minimize side effects and improve adherence to supplementation
Integrate iron supplementation into broader maternal and child health programs
3. Target Groups for Iron Supplementation
Pregnant women: To meet increased iron demands and reduce risks of maternal anemia and low birth weight
Infants and young children (6 months to 5 years): To support growth and cognitive development
Adolescent girls: To address increased requirements during growth and menstruation
Individuals with diagnosed iron deficiency anemia: As part of therapeutic management
4. Dosage and Administration
Population
Recommended Dose
Duration
Pregnant women
60 mg elemental iron daily
From first antenatal visit until 3 months postpartum
Infants (6–24 months)
10–12.5 mg elemental iron daily
At least 3 months
Children (2–5 years)
30 mg elemental iron daily
At least 3 months
Adolescents
30–60 mg elemental iron daily
3 months or as per clinical need
Therapeutic (all ages)
3–6 mg/kg/day elemental iron in divided doses
3 months or until hemoglobin normalizes
Prefer oral iron salts (ferrous sulfate, ferrous fumarate, ferrous gluconate)
Take iron supplements on an empty stomach or with vitamin C-rich foods to enhance absorption
Avoid concurrent intake with calcium-rich foods or antacids
5. Monitoring and Follow-up
Assess hemoglobin and ferritin levels before starting therapy and after 4–6 weeks
Monitor for side effects such as gastrointestinal discomfort, constipation, or nausea
Encourage adherence through counseling and management of side effects
Adjust dose based on response and tolerability
6. Managing Side Effects
Take supplements with food if gastrointestinal upset occurs
Use slow-release formulations if available and necessary
Encourage adequate hydration and dietary fiber to prevent constipation
Educate patients on the importance of continuing therapy despite mild side effects
7. Contraindications and Cautions
Iron supplementation is contraindicated in cases of hemochromatosis or other iron overload disorders
Caution in patients with inflammatory bowel disease or gastrointestinal ulcers
Ensure diagnosis of iron deficiency before initiating therapy to avoid unnecessary supplementation
8. Integration with Other Health Programs
Combine iron supplementation with deworming programs in endemic areas
Incorporate in antenatal care, child health visits, and school health programs
Iron supplementation is a safe, cost-effective strategy to prevent and treat iron deficiency anemia. Neftaly supports healthcare providers with practical guidelines to improve iron status and health outcomes in vulnerable populations.
For patient education materials, training resources, and supply management tools, contact Neftaly Nutrition Services.
Delivering Lifesaving Care in the First Moments of Life
At Neftaly, we understand that the moments immediately after birth are critical—especially for newborns who experience difficulty initiating or sustaining effective breathing. Our Neonatal Resuscitation Guidelines are designed to ensure that all healthcare professionals are prepared to respond quickly, skillfully, and safely to any neonatal emergency. Grounded in international best practices, Neftaly’s protocols support positive outcomes and reduce the risk of neonatal morbidity and mortality.
Our Mission
To ensure that every newborn receives immediate, effective, and evidence-based resuscitation care when needed—no matter the setting or circumstances.
Key Principles of Neonatal Resuscitation
Every birth should be attended by someone trained in neonatal resuscitation.
Anticipation and preparation are essential—especially for high-risk deliveries.
Initial steps of resuscitation focus on warmth, airway management, and breathing support.
Effective ventilation is the most critical intervention in neonatal resuscitation.
Continuous assessment of heart rate, breathing, and tone guides every action.
Regular training using simulation-based neonatal resuscitation scenarios.
Certification and re-certification in accordance with local and international standards (e.g., NRP).
Team debriefing and quality improvement after every resuscitation event.
Why Neftaly?
Evidence-based protocols aligned with WHO and NRP guidelines
Multidisciplinary approach involving midwives, nurses, neonatologists, and pediatricians
Commitment to quality, safety, and compassion in every birth
Ongoing staff development and clinical governance
Conclusion
The first minutes of life can determine a lifetime. With Neftaly Neonatal Resuscitation Guidelines, healthcare teams are empowered to act quickly, skillfully, and confidently—giving every newborn the best possible start.
Heart failure (HF) is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection of blood. At Neftaly, our heart failure management guidelines are designed to align with international best practices while addressing local healthcare realities. Our goal is to provide a standardized, patient-centered approach to diagnosing, treating, and monitoring heart failure effectively.
1. Diagnosis and Initial Assessment
Early and accurate diagnosis is critical to improving outcomes. Neftaly recommends:
✔ Clinical Evaluation
Assessment of signs and symptoms (e.g., dyspnea, fatigue, edema, orthopnea)
Detailed patient history including risk factors (e.g., hypertension, diabetes, coronary artery disease)
✔ Diagnostic Tools
Echocardiogram: To assess ejection fraction (HFrEF, HFpEF, HFmrEF)
BNP/NT-proBNP Testing: For diagnostic support and monitoring
ECG and Chest X-ray: To identify underlying structural abnormalities
Laboratory Testing: Including renal function, electrolytes, thyroid function, and iron studies
2. Classification of Heart Failure
HFrEF (Heart Failure with reduced Ejection Fraction): EF ≤ 40%
HFpEF (Heart Failure with preserved Ejection Fraction): EF ≥ 50%
HFmrEF (Mildly reduced EF): EF 41–49%
Treatment approaches differ based on classification and underlying etiology.
3. Pharmacologic Management
Neftaly guidelines emphasize evidence-based medication use to reduce mortality and hospitalizations:
For HFrEF:
ACE Inhibitors / ARBs / ARNIs – For reducing symptoms and mortality
Beta-Blockers – Carvedilol, bisoprolol, or metoprolol succinate
Patient Education: On symptom recognition, medication adherence, and when to seek care
Cardiac Rehabilitation: Especially post-discharge or after acute decompensation
Vaccinations: Annual flu and pneumococcal vaccines
5. Device and Advanced Therapies
Implantable Cardioverter Defibrillators (ICD) for patients with HFrEF and reduced EF despite optimal therapy
Cardiac Resynchronization Therapy (CRT) for select patients with dyssynchrony
Referral for Advanced Therapies (LVAD, transplant) in end-stage heart failure
6. Follow-Up and Monitoring
Regular clinical reviews to monitor symptoms, weight, vitals, and medication effectiveness
Laboratory testing for kidney function and electrolytes, especially after initiating or adjusting medications
Monitoring for adherence, depression, and psychosocial support needs
7. Palliative and End-of-Life Care
Neftaly emphasizes integrating palliative care early in advanced heart failure to manage symptoms and ensure patient comfort and dignity. Discussions on care preferences and advance directives are essential.
Implementation in Clinical Practice
Neftaly supports healthcare providers through:
Training and Workshops
Clinical Decision Support Tools
Care Pathways and Referral Protocols
Community-Based Management Models for low-resource settings
Neftaly’s Commitment
We aim to reduce the burden of heart failure by delivering consistent, high-quality care through structured guidelines, multidisciplinary collaboration, and patient empowerment.
Neftaly Iron Supplementation Guidelines: Supporting Optimal Iron Health Across Populations
Iron deficiency is one of the most common nutritional deficiencies worldwide, affecting people of all ages—especially women, children, and individuals with chronic conditions. Left untreated, it can lead to anemia, fatigue, impaired cognitive development, and complications in pregnancy. Neftaly’s Iron Supplementation Guidelines provide clear, evidence-based protocols to help healthcare providers deliver targeted, safe, and effective iron supplementation across clinical and community settings.
The Challenge: Widespread Deficiency, Inconsistent Care
Iron needs vary significantly by age, sex, health status, and diet. Yet, supplementation is often applied in a one-size-fits-all approach, leading to:
Under-treatment of at-risk individuals
Over-supplementation and iron overload in others
Poor adherence due to side effects
Inconsistent screening and follow-up practices
Neftaly’s Comprehensive Iron Supplementation Framework
Neftaly delivers standardized, actionable guidelines that support accurate diagnosis, individualized supplementation plans, and ongoing monitoring for better health outcomes.
Key Features:
Risk-Based Screening Protocols: Guidelines for screening high-risk groups including pregnant women, infants, menstruating women, adolescents, and those with chronic illnesses.
Dosage Recommendations by Demographics: Age- and condition-specific dosage guidance based on WHO and national clinical standards.
Oral and Intravenous Supplementation Guidance: Step-by-step instructions for safe administration, including when to transition from oral to IV iron.
Side Effect Management: Strategies to reduce common side effects such as gastrointestinal discomfort, improving patient adherence.
Monitoring and Follow-Up Tools: Timelines and lab testing protocols (e.g., hemoglobin, ferritin) to evaluate effectiveness and adjust treatment.
Nutrition and Education Support: Integrated advice on dietary sources of iron and patient education materials in multiple languages.
Benefits for Providers and Patients:
Improved Diagnosis and Treatment: More accurate targeting of supplementation reduces risks of both deficiency and overload.
Increased Adherence and Outcomes: Personalized dosing and side-effect management lead to better patient engagement.
Reduced Complications: Prevents anemia-related risks such as fatigue, developmental delays, and pregnancy complications.
Streamlined Workflows: Standardized tools simplify implementation across diverse healthcare settings.
Supports Public Health Goals: Contributes to national and global anemia reduction strategies with measurable, scalable practices.
Strengthening Iron Health with Neftaly
Neftaly’s Iron Supplementation Guidelines empower providers with the tools they need to deliver safe, effective, and personalized care. From frontline health workers to clinical specialists, Neftaly supports a unified, data-driven approach to eliminating iron deficiency and promoting lifelong well-being.
